data. Overall, our results suggest that NaChBac achieves selectivity for Na by a unique molecular strategy.
Humboldt University Berlin, Berlin, Germany, 2 German Cancer Research Center, Berlin, Germany. The influenza virus hemagglutinin (HA) is known to play an essential role in virus infection. It is involved in cell receptor binding and uptake by endocytosis and, after internalization and trafficking to early and late endosomes, induces membrane fusion leading to the release of the viral genome into the cell. This fusion process is mediated by a water-driven ''spring-loaded mechanism'' which is initiated by protonation of the HA1 globular heads in the acidic environment of the endosome. It has been shown for the HA of influenza virus X-31 that the pH of fusion can be shifted to higher or lower pH values by introducing or deleting salt bridges in the ectodomain of the glycoprotein. In particular, a mutation at the distal end of HA1 leading to the introduction of a salt bridge between two monomers significantly enhanced its stability thereby abolishing membrane fusion. It was suggested that this mutation is also involved in the development of new human pathogenic H5N1 lineages. We hypothesize that salt bridges in the HA1 ectodomain regulate replication efficiency and pathogenesis. As a proof of principle recombinant virus particles containing the wild type or mutant HA of X-31 strain were produced and assayed by fluorescence dequenching. Fusion activity of mutant HA was significantly reduced with increasing pH compared to the wild type, suggesting an influence of the salt bridge on viral fusion. We will apply these results on avian HA and measure virus-endosome fusion by real time imaging inside living cells. Using human and avian cells we will be able to observe possible variations in endosomal pH and in membrane fusion activity. This work was supported by the Marie Curie Actions 7 th framework program of Initial Training Networks. We have recently shown that HIV enters target cells by fusing with endosomes, whereas its fusion with the plasma membrane does not proceed beyond the lipid mixing step. However, the mechanism of restriction of the HIV fusion at the cell surface and/or the factors that aid the virus entry from endosomes remain unclear. Here, we examined the HIV entry into a panel of target cells lines and into primary CD4 þ T cells. Kinetic measurements of fusion combined with time-resolved single virus imaging further supported the notion that HIV enters the cells via endocytosis and fusion with endosomes. To determine whether there is a block for HIV fusion at the cell surface, we attempted to redirect fusion to the plasma membrane. Two experimental strategies were employed. First, fusion was synchronized by pre-incubating the viruses with cells at room temperature to allow CD4 and coreceptors engagement while preventing the virus uptake or fusion. However, subsequent shift to 37 o C triggered quick virus uptake followed by endosomal fusion without allowing direct fusion at the cell surface. An alternative approach to redirect HIV-1 fusion was through blocking its endocytosis by a small-molecule dynamin inhibitor, dynasore. Treatment with dynasore resulted in transfer of viral lipids to the plasma membrane and virus inactivation without any detectable release of the viral content into the cytosol. Thus, in spite of the extended window of opportunity for entering from the cell surface, HIV-1 fusion failed to progress beyond the lipid mixing step. Our results further support the notion that HIV enters disparate cell types through endocytosis and fusion with endosomes. This work has been supported by the NIH GM054787 grant. In vitro reconstitution experiments have played an essential role in a large body of research on SNARE-mediated membrane fusion. We and others have developed single vesicle assays to gain more detailed insight into the kinetics of vesicle docking and fusion. Previously, we used supported membranes in combination with total internal reflection microscopy (TIRFM) to record the docking and fusion of vesicles containing recombinant Synaptobrevin2 (Syb2) to an acceptor SNARE complex consisting of one Syntaxin 1a (Syx1a), one SNAP25 (SN25) and a short Syb2 fragment (Syb49-96) to ensure a 1:1 stoichiometry between Syx1a and SN25. Here we report experiments in which the Syb2 containing vesicles were replaced by synaptic vesicles (SV) purified from rat brain. Docking and fusion of synaptic vesicles with supported membranes is efficient, fast (~35 ms) and SNARE dependent. The fusion kinetics obtained with different lipid environments in the supported membrane and under different salt conditions are compared to the kinetics measured with reconstituted Syb2 vesicles. Membrane fusion is an essential process in infection by enveloped viruses, synaptic exocytosis, and vesicle trafficking. As interacting membranes are brought together prior to fusion, the resulting membrane-water-membrane interface has surprising and non-bulk-like properties. Here we ask two questions regarding this membrane-membrane interface: how does the physical chemistry differ from bulk, and how do fusion peptides affect this interface. We have used atomistic molecular dynamics simulation to study these interfacial behavior at high resolution. At vesicle-vesicle interfaces prior to fusion, we observe in our simulations a distinct ordering of water between the two membranes and a concomitant slowing of dynamics. We used committor analysis to examine the role of fine water structure in fusion; holding the vesicles fixed while resampling water conformations from a solvent box substantially speeds fusion dynamics, with a small but significant effect on fusion energetics. These slowed dynamics may provide another reason for the reported propensity of fusion stalks to form around the periphery of a contact interface. We have also examined the effect of influenza fusion peptides in bilayers and at membrane interfaces. We and others have previously hypothesized that lipid tail protrusion is a precursor to fusion stalk formation. In our simulations, influenza fusion peptides promote tail protrusion most strongly in a kinked helix conformation with the ends inserted into the hydrophobic layer. Straight helix and helical hairpin conformations occupying an interfacial position promote tail protrusion less strongly. In an attempt to develop a minimal model system of cell membrane fusion in the absence of external catalysts we have used large unilamellar vesicles 604a consisting of a phospholipid (dioleoylphosphatidylcholine), cholesterol and diacylglycerol in a 50:50:3 mol ratio. In this protein-free system, fusion occurs just by thermal fluctuations, above 60 C. Under our conditions cholesterol is essential to produce vesicle aggregation, but fusion is only observed when small amounts of diacylglycerol are added. Vesicle fusion occurs only under conditions when X-ray diffraction and cryo-transmission electron microscopy of the lipid mixtures used in vesicle preparation show inverted lipid phase formation (hexagonal and cubic). We have previously shown that DNA-lipid conjugates can be used to mediate membrane fusion between small vesicles and also to construct membrane architectures, such as a DNA-tethered lipid bilayer patch which is distanced from a glass coverslip by 8 nm long DNA duplex tethers. We currently employ these bilayer patches in a model vesicle fusion system, studying the fusion (both lipid-mixing and content-mixing) of small vesicles to the bilayer patches, where fusion is mediated by complementary DNA-lipid partners in a geometry similar to that of SNARE-mediated membrane fusion. This model system allows us to quantitatively describe important aspects of membrane fusion, such as the dependence of fusion on DNA-lipid concentration, the numbers of DNA-duplexes involved in the fusion process, the role of proximity and membrane curvature on the fusion reaction. We have also developed a kinetic model describing the distribution of docking-to-fusion wait times and find that these wait times are exponentially distributed, implying a stochastic process which initiates fusion. Insights into the biological membrane fusion process are discussed. Crucell BV, Leiden, Netherlands. Influenza viruses have hundreds of hemagglutinin (HA) protein trimers embedded in their phospholipid envelope. The HA protein is the lynchpin in the first stage of influenza infection, first by facilitating binding and internalization into target host cells and then by mediating fusion with the membrane of late endosomes. Recently, antibodies capable of neutralizing both group 1 and group 2 influenza A viruses have been described [Science,v324,p246,2009; Science,v333,p843,2011] . These broadly neutralizing HA stem-binding antibodies appear to act by blocking the HA conformational change necessary for fusion. Here, we have visualized the interplay between a virus and antibodies during neutralization using our recently developed single-particle fusion assay [PNAS,v105(40),p15382,2008] . To this end, antibodies and infectious viral particles were fluorescently labeled and incubated together. Viruses were then bound to sialic acid decorated proteins incorporated into a planar, supported phospholipid bilayer and fusion induced by addition of an acidic buffer. Using TIRF microscopy, individual hemifusion events were observed as the rapid release of lipophilic dye from the viral membrane into the target bilayer. This novel approach allows us to directly link the action of individual HA-binding antibodies to viral fusion events, providing new insight into the mechanism and molecular stoichiometry involved in fusion and neutralizationinformation obfuscated in traditional cell-cell and bulk fusion assays. We see a concentration dependent effect of inhibiting antibodies on the time it takes for viruses to undergo hemifusion as well as on the total number of hemifusion events. Furthermore, we can correlate the fluorescence intensity per virion to the number of bound antibodies and thereby directly measure the number of HA molecules involved in fusion. More to the point, our results have explicit implications for the model of bilayer fusion arising from the coordinated efforts of multiple hemagglutinins.
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A Microfluidic Device for Single Cell-Liposome Fusion Phillip Kuhn, Klaus Eyer, Petra S. Dittrich. ETH Zurich, Zurich, Switzerland. The fusion of lipid membranes is ubiquitous in living organisms and allows the transfer of membrane-impermeable molecules across the cell membrane and different cell compartments. With the aim to systematically investigate membrane fusion, we developed an advanced microfluidic device that facilitates the close contact positioning of single cells and small unilamellar vesicles (SUVs) and enables chemically induced fusion. The SUVs were immobilized on discrete, micro contact printed spots on a glass surface. For vesicle immobilization, we used biotin-PEG-cholesterol bound to immobilized avidin. Supply of the SUVs at low flow rates and incubation times of a few minutes enabled efficient immobilization of the SUVs on the designated areas due to the insertion of cholesterol into the lipid membrane. The patterned glass was covered by a microfluidic device made of poly(dimethylsiloxane)(PDMS) that contained the micro-channels for fluid supply and an integrated array of one hundred geometric hurdles to trap individual cells. We studied the fusion of cells that are trapped just above the immobilized SUVs by using total internal reflection fluorescence microscopy and wide field fluorescence microscopy. In preliminary experiments, the pH-induced fusions of suspension cells (U937) to SUVs prepared from anionic and fusogenic phospholipids (DOPG and DOPE) were investigated. A fluorescence dequenching assay with two fluorophores (R18 and HPTS) was employed to visualize, in real time, the fusion of cell and liposome membranes and the release of the liposome's enclosed fluids into the cytosol. The novel platform will expand our knowledge of essential cellular processes. Moreover, it facilitates screening of optimal fusion parameters and hence, could improve the typically low efficiency of cell lipofection to deliver DNA and other biomolecules into the cytosol. This would ultimately lead to novel therapeutic strategies, e.g. against cancer.
Platform: Membrane Transporters & Exchangers II
3078-Plat Towards a Structural Understanding of Alternating Access within the Proton Dependent Oligopeptide Transporter (POT) Family Simon Newstead. University of Oxford, Oxford, United Kingdom. Recently we determined the first crystal structure of a member of the Proton dependent Oligopeptide Transporter (POT) family, PepTSo, a prokaryotic homologue of the mammalian PepT1 and PepT2 proteins. PepT1 and PepT2 are responsible for the uptake and re-absorption of dietary peptides and have a direct effect on the oral bioavailability of important drug families. POT family transporters belong to the Major Facilitator Superfamily (MFS) of secondary active transport proteins and contain between 12 and 14 transmembrane helices. The structure of PepTSo revealed a ligand bound occluded state that was noticeably asymmetric between the two canonical N-and C-terminal six helical bundles present in MFS members. To gain further insight into the transport mechanism of the POT family we have determined the structure of a second member to 3.3 Angstrom resolution. Compared to PepTSo, this second structure reveals an essentially symmetric inward open conformation. Here we present the analysis of this structure and show that using previously identified inverted topology repeats present within the MFS fold we can create a model for the currently missing outward open conformation. We further provide experimental evidence for the outward open model using double electron electron resonance (DEER) measurements. These two crystal structures, combined with the repeat swapped model, essentially describe the basic set of conformations required for the alternating access model of transport within this pharmaceutically important family of MFS transporters.
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Conformational Transition Pathway of GlpT Transporter, Characterized by Nonequilibrium Molecular Dynamics Simulations Mahmoud Moradi, Giray Enkavi, Emad Tajkhorshid. University of Illinois at Urbana-Champaign, Urbana, IL, USA. Glycerol-3-phosphate transporter (GlpT) is a member of major facilitator superfamily (MFS), the largest family of secondary transporters. Similar to other transporters, GlpT is believed to function using an ''alternating-access'' mechanism during which it undergoes large conformational changes. The only available structure of GlpT is in the apo inward-facing (IF) state. In our earlier work using equilibrium molecular dynamics (MD) simulations, the binding site of GlpT was characterized and the initial substrate-induced closing on
